National OncoVenture   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Going Korea, Republic of (2011)

Organization Overview

First Clinical Trial
2012
NCT01746771
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National OncoVenture | National OncoVenture (i20371@ncc.re.kr) | National OncoVenture (jyk1949@ncc.re.kr) | National OncoVenture (minchae@ncc.re.kr) | National OncoVenture/National Cancer Center